nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—MPO—Octreotide—thymus cancer	0.726	1	CbGbCtD
Mesalazine—Steatorrhoea—Octreotide—thymus cancer	0.0124	0.0718	CcSEcCtD
Mesalazine—Malabsorption—Octreotide—thymus cancer	0.00895	0.0519	CcSEcCtD
Mesalazine—Faeces discoloured—Octreotide—thymus cancer	0.00749	0.0435	CcSEcCtD
Mesalazine—Breast feeding—Octreotide—thymus cancer	0.00372	0.0216	CcSEcCtD
Mesalazine—Rectal tenesmus—Octreotide—thymus cancer	0.00349	0.0202	CcSEcCtD
Mesalazine—CHUK—hematopoietic system—thymus cancer	0.00339	0.0608	CbGeAlD
Mesalazine—Hepatitis cholestatic—Octreotide—thymus cancer	0.00323	0.0187	CcSEcCtD
Mesalazine—CHUK—epithelium—thymus cancer	0.0031	0.0556	CbGeAlD
Mesalazine—Prostatic disorder—Octreotide—thymus cancer	0.00306	0.0177	CcSEcCtD
Mesalazine—Pancreatitis acute—Octreotide—thymus cancer	0.00281	0.0163	CcSEcCtD
Mesalazine—Proctalgia—Octreotide—thymus cancer	0.00277	0.0161	CcSEcCtD
Mesalazine—Abdominal bloating—Octreotide—thymus cancer	0.00273	0.0158	CcSEcCtD
Mesalazine—Rectal disorder—Octreotide—thymus cancer	0.00265	0.0154	CcSEcCtD
Mesalazine—Anorectal disorder—Octreotide—thymus cancer	0.00247	0.0143	CcSEcCtD
Mesalazine—Ear disorder—Octreotide—thymus cancer	0.00241	0.014	CcSEcCtD
Mesalazine—CHUK—lymphoid tissue—thymus cancer	0.00239	0.0428	CbGeAlD
Mesalazine—Anorectal discomfort—Octreotide—thymus cancer	0.00238	0.0138	CcSEcCtD
Mesalazine—Local reaction—Octreotide—thymus cancer	0.00235	0.0136	CcSEcCtD
Mesalazine—IKBKB—hematopoietic system—thymus cancer	0.00231	0.0413	CbGeAlD
Mesalazine—CHUK—Canonical NF-kappaB pathway—CYLD—thymus cancer	0.00227	0.0497	CbGpPWpGaD
Mesalazine—Cholecystitis—Octreotide—thymus cancer	0.00226	0.0131	CcSEcCtD
Mesalazine—Gastrointestinal symptom NOS—Octreotide—thymus cancer	0.00221	0.0128	CcSEcCtD
Mesalazine—Haemorrhoids—Octreotide—thymus cancer	0.00221	0.0128	CcSEcCtD
Mesalazine—CHUK—thyroid gland—thymus cancer	0.00217	0.0389	CbGeAlD
Mesalazine—Transaminases increased—Octreotide—thymus cancer	0.00214	0.0124	CcSEcCtD
Mesalazine—Cholelithiasis—Octreotide—thymus cancer	0.00209	0.0121	CcSEcCtD
Mesalazine—IKBKB—Canonical NF-kappaB pathway—CYLD—thymus cancer	0.00206	0.0451	CbGpPWpGaD
Mesalazine—Nail disorder—Octreotide—thymus cancer	0.002	0.0116	CcSEcCtD
Mesalazine—CHUK—lung—thymus cancer	0.00197	0.0353	CbGeAlD
Mesalazine—PPARG—neck—thymus cancer	0.00193	0.0345	CbGeAlD
Mesalazine—Abdominal cramps—Octreotide—thymus cancer	0.00192	0.0112	CcSEcCtD
Mesalazine—ALOX5—hematopoietic system—thymus cancer	0.00191	0.0342	CbGeAlD
Mesalazine—Intestinal obstruction—Octreotide—thymus cancer	0.00191	0.0111	CcSEcCtD
Mesalazine—Burning sensation—Octreotide—thymus cancer	0.00187	0.0108	CcSEcCtD
Mesalazine—Metrorrhagia—Octreotide—thymus cancer	0.00182	0.0106	CcSEcCtD
Mesalazine—Throat sore—Octreotide—thymus cancer	0.0018	0.0105	CcSEcCtD
Mesalazine—CHUK—NOD1/2 Signaling Pathway—CYLD—thymus cancer	0.00179	0.0391	CbGpPWpGaD
Mesalazine—Oropharyngeal discomfort—Octreotide—thymus cancer	0.00179	0.0104	CcSEcCtD
Mesalazine—IKBKB—pituitary gland—thymus cancer	0.00171	0.0307	CbGeAlD
Mesalazine—Cholestasis—Octreotide—thymus cancer	0.00171	0.00992	CcSEcCtD
Mesalazine—IKBKB—lymphoid tissue—thymus cancer	0.00162	0.0291	CbGeAlD
Mesalazine—IKBKB—NOD1/2 Signaling Pathway—CYLD—thymus cancer	0.00162	0.0355	CbGpPWpGaD
Mesalazine—MPO—hematopoietic system—thymus cancer	0.00162	0.029	CbGeAlD
Mesalazine—Acne—Octreotide—thymus cancer	0.00154	0.00896	CcSEcCtD
Mesalazine—Breast pain—Octreotide—thymus cancer	0.00149	0.00864	CcSEcCtD
Mesalazine—MPO—epithelium—thymus cancer	0.00148	0.0265	CbGeAlD
Mesalazine—Jaundice cholestatic—Octreotide—thymus cancer	0.00148	0.00858	CcSEcCtD
Mesalazine—Amenorrhoea—Octreotide—thymus cancer	0.00148	0.00858	CcSEcCtD
Mesalazine—IKBKB—thyroid gland—thymus cancer	0.00148	0.0264	CbGeAlD
Mesalazine—Rectal haemorrhage—Octreotide—thymus cancer	0.00144	0.00834	CcSEcCtD
Mesalazine—PPARG—hematopoietic system—thymus cancer	0.00144	0.0257	CbGeAlD
Mesalazine—Arthropathy—Octreotide—thymus cancer	0.00143	0.00829	CcSEcCtD
Mesalazine—Oropharyngeal pain—Octreotide—thymus cancer	0.00143	0.00829	CcSEcCtD
Mesalazine—CHUK—lymph node—thymus cancer	0.00135	0.0241	CbGeAlD
Mesalazine—ALOX5—lymphoid tissue—thymus cancer	0.00135	0.0241	CbGeAlD
Mesalazine—IKBKB—lung—thymus cancer	0.00134	0.024	CbGeAlD
Mesalazine—PPARG—epithelium—thymus cancer	0.00131	0.0235	CbGeAlD
Mesalazine—CHUK—TNF receptor signaling pathway —CYLD—thymus cancer	0.0013	0.0285	CbGpPWpGaD
Mesalazine—Phosphatase alkaline increased—Octreotide—thymus cancer	0.0013	0.00754	CcSEcCtD
Mesalazine—Vaginal inflammation—Octreotide—thymus cancer	0.0013	0.00754	CcSEcCtD
Mesalazine—Eructation—Octreotide—thymus cancer	0.00128	0.0074	CcSEcCtD
Mesalazine—Cystitis noninfective—Octreotide—thymus cancer	0.00127	0.00736	CcSEcCtD
Mesalazine—Influenza like illness—Octreotide—thymus cancer	0.00126	0.00732	CcSEcCtD
Mesalazine—Cystitis—Octreotide—thymus cancer	0.00125	0.00728	CcSEcCtD
Mesalazine—Candida infection—Octreotide—thymus cancer	0.00124	0.0072	CcSEcCtD
Mesalazine—Vaginal infection—Octreotide—thymus cancer	0.00123	0.00712	CcSEcCtD
Mesalazine—ALOX5—bone marrow—thymus cancer	0.00123	0.022	CbGeAlD
Mesalazine—ALOX5—thyroid gland—thymus cancer	0.00122	0.0219	CbGeAlD
Mesalazine—CHUK—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CYLD—thymus cancer	0.00122	0.0267	CbGpPWpGaD
Mesalazine—Neuropathy—Octreotide—thymus cancer	0.00122	0.00708	CcSEcCtD
Mesalazine—MPO—pituitary gland—thymus cancer	0.0012	0.0215	CbGeAlD
Mesalazine—Cramps of lower extremities—Octreotide—thymus cancer	0.00119	0.00692	CcSEcCtD
Mesalazine—IKBKB—TNF receptor signaling pathway —CYLD—thymus cancer	0.00118	0.0259	CbGpPWpGaD
Mesalazine—Mouth ulceration—Octreotide—thymus cancer	0.00117	0.00681	CcSEcCtD
Mesalazine—Bladder pain—Octreotide—thymus cancer	0.00117	0.00681	CcSEcCtD
Mesalazine—MPO—lymphoid tissue—thymus cancer	0.00114	0.0204	CbGeAlD
Mesalazine—ALOX5—lung—thymus cancer	0.00111	0.0199	CbGeAlD
Mesalazine—IKBKB—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CYLD—thymus cancer	0.00111	0.0242	CbGpPWpGaD
Mesalazine—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.00108	0.00629	CcSEcCtD
Mesalazine—Gastroenteritis—Octreotide—thymus cancer	0.00106	0.00617	CcSEcCtD
Mesalazine—Deafness—Octreotide—thymus cancer	0.00105	0.00612	CcSEcCtD
Mesalazine—MPO—bone marrow—thymus cancer	0.00104	0.0186	CbGeAlD
Mesalazine—PPARG—lymphoid tissue—thymus cancer	0.00101	0.0181	CbGeAlD
Mesalazine—Arthritis—Octreotide—thymus cancer	0.00097	0.00563	CcSEcCtD
Mesalazine—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.000943	0.00547	CcSEcCtD
Mesalazine—Osteoarthritis—Octreotide—thymus cancer	0.000943	0.00547	CcSEcCtD
Mesalazine—MPO—lung—thymus cancer	0.00094	0.0168	CbGeAlD
Mesalazine—PPARG—bone marrow—thymus cancer	0.00092	0.0165	CbGeAlD
Mesalazine—PPARG—thyroid gland—thymus cancer	0.000918	0.0164	CbGeAlD
Mesalazine—IKBKB—lymph node—thymus cancer	0.000917	0.0164	CbGeAlD
Mesalazine—Dry skin—Octreotide—thymus cancer	0.000864	0.00501	CcSEcCtD
Mesalazine—Abdominal pain upper—Octreotide—thymus cancer	0.000861	0.005	CcSEcCtD
Mesalazine—Cramp muscle—Octreotide—thymus cancer	0.000849	0.00493	CcSEcCtD
Mesalazine—Nasopharyngitis—Octreotide—thymus cancer	0.000843	0.00489	CcSEcCtD
Mesalazine—CHUK—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—CYLD—thymus cancer	0.000838	0.0183	CbGpPWpGaD
Mesalazine—Gastritis—Octreotide—thymus cancer	0.000835	0.00484	CcSEcCtD
Mesalazine—PPARG—lung—thymus cancer	0.000834	0.0149	CbGeAlD
Mesalazine—Abdominal distension—Octreotide—thymus cancer	0.000821	0.00476	CcSEcCtD
Mesalazine—Influenza—Octreotide—thymus cancer	0.000815	0.00473	CcSEcCtD
Mesalazine—Asthma—Octreotide—thymus cancer	0.000815	0.00473	CcSEcCtD
Mesalazine—Bronchospasm—Octreotide—thymus cancer	0.000802	0.00465	CcSEcCtD
Mesalazine—Pancreatitis—Octreotide—thymus cancer	0.000799	0.00464	CcSEcCtD
Mesalazine—MPO—IL23-mediated signaling events—CD4—thymus cancer	0.000794	0.0174	CbGpPWpGaD
Mesalazine—Bronchitis—Octreotide—thymus cancer	0.000784	0.00455	CcSEcCtD
Mesalazine—Abdominal discomfort—Octreotide—thymus cancer	0.000781	0.00453	CcSEcCtD
Mesalazine—PTGS1—hematopoietic system—thymus cancer	0.000768	0.0137	CbGeAlD
Mesalazine—Dysuria—Octreotide—thymus cancer	0.000762	0.00442	CcSEcCtD
Mesalazine—IKBKB—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—CYLD—thymus cancer	0.00076	0.0166	CbGpPWpGaD
Mesalazine—ALOX5—lymph node—thymus cancer	0.00076	0.0136	CbGeAlD
Mesalazine—Upper respiratory tract infection—Octreotide—thymus cancer	0.000758	0.00439	CcSEcCtD
Mesalazine—Pollakiuria—Octreotide—thymus cancer	0.000753	0.00437	CcSEcCtD
Mesalazine—Weight increased—Octreotide—thymus cancer	0.000742	0.0043	CcSEcCtD
Mesalazine—Weight decreased—Octreotide—thymus cancer	0.000737	0.00428	CcSEcCtD
Mesalazine—PTGS2—hematopoietic system—thymus cancer	0.000734	0.0131	CbGeAlD
Mesalazine—Pneumonia—Octreotide—thymus cancer	0.000731	0.00424	CcSEcCtD
Mesalazine—MPO—IL23-mediated signaling events—IL2—thymus cancer	0.000731	0.016	CbGpPWpGaD
Mesalazine—Depression—Octreotide—thymus cancer	0.000725	0.0042	CcSEcCtD
Mesalazine—Neuropathy peripheral—Octreotide—thymus cancer	0.000712	0.00413	CcSEcCtD
Mesalazine—Jaundice—Octreotide—thymus cancer	0.000708	0.00411	CcSEcCtD
Mesalazine—Urinary tract infection—Octreotide—thymus cancer	0.000706	0.0041	CcSEcCtD
Mesalazine—Conjunctivitis—Octreotide—thymus cancer	0.000706	0.0041	CcSEcCtD
Mesalazine—PTGS1—epithelium—thymus cancer	0.000702	0.0126	CbGeAlD
Mesalazine—Haematuria—Octreotide—thymus cancer	0.000693	0.00402	CcSEcCtD
Mesalazine—Hepatobiliary disease—Octreotide—thymus cancer	0.000687	0.00399	CcSEcCtD
Mesalazine—Epistaxis—Octreotide—thymus cancer	0.000685	0.00398	CcSEcCtD
Mesalazine—Sinusitis—Octreotide—thymus cancer	0.000682	0.00396	CcSEcCtD
Mesalazine—PTGS2—epithelium—thymus cancer	0.000671	0.012	CbGeAlD
Mesalazine—Rhinitis—Octreotide—thymus cancer	0.000654	0.00379	CcSEcCtD
Mesalazine—Hepatitis—Octreotide—thymus cancer	0.000652	0.00378	CcSEcCtD
Mesalazine—Pharyngitis—Octreotide—thymus cancer	0.000647	0.00376	CcSEcCtD
Mesalazine—MPO—lymph node—thymus cancer	0.000643	0.0115	CbGeAlD
Mesalazine—Oedema peripheral—Octreotide—thymus cancer	0.000643	0.00373	CcSEcCtD
Mesalazine—Tinnitus—Octreotide—thymus cancer	0.000608	0.00353	CcSEcCtD
Mesalazine—Cardiac disorder—Octreotide—thymus cancer	0.000605	0.00351	CcSEcCtD
Mesalazine—Immune system disorder—Octreotide—thymus cancer	0.000589	0.00342	CcSEcCtD
Mesalazine—PTGS1—cardiac atrium—thymus cancer	0.000583	0.0104	CbGeAlD
Mesalazine—Alopecia—Octreotide—thymus cancer	0.000576	0.00334	CcSEcCtD
Mesalazine—Mental disorder—Octreotide—thymus cancer	0.000572	0.00332	CcSEcCtD
Mesalazine—PPARG—lymph node—thymus cancer	0.00057	0.0102	CbGeAlD
Mesalazine—PTGS1—pituitary gland—thymus cancer	0.000569	0.0102	CbGeAlD
Mesalazine—CHUK—TCR signaling in naïve CD8+ T cells—CD8A—thymus cancer	0.000569	0.0124	CbGpPWpGaD
Mesalazine—Erythema—Octreotide—thymus cancer	0.000568	0.00329	CcSEcCtD
Mesalazine—Flatulence—Octreotide—thymus cancer	0.00056	0.00325	CcSEcCtD
Mesalazine—Tension—Octreotide—thymus cancer	0.000557	0.00323	CcSEcCtD
Mesalazine—Nervousness—Octreotide—thymus cancer	0.000552	0.0032	CcSEcCtD
Mesalazine—Back pain—Octreotide—thymus cancer	0.000549	0.00319	CcSEcCtD
Mesalazine—Muscle spasms—Octreotide—thymus cancer	0.000546	0.00317	CcSEcCtD
Mesalazine—PTGS2—pituitary gland—thymus cancer	0.000544	0.00975	CbGeAlD
Mesalazine—MPO—C-MYB transcription factor network—KIT—thymus cancer	0.000539	0.0118	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—CYLD—thymus cancer	0.000539	0.0118	CbGpPWpGaD
Mesalazine—Vision blurred—Octreotide—thymus cancer	0.000535	0.00311	CcSEcCtD
Mesalazine—Tremor—Octreotide—thymus cancer	0.000532	0.00309	CcSEcCtD
Mesalazine—Ill-defined disorder—Octreotide—thymus cancer	0.000527	0.00306	CcSEcCtD
Mesalazine—Anaemia—Octreotide—thymus cancer	0.000525	0.00305	CcSEcCtD
Mesalazine—PTGS2—lymphoid tissue—thymus cancer	0.000517	0.00925	CbGeAlD
Mesalazine—IKBKB—TCR signaling in naïve CD8+ T cells—CD8A—thymus cancer	0.000516	0.0113	CbGpPWpGaD
Mesalazine—Malaise—Octreotide—thymus cancer	0.000512	0.00297	CcSEcCtD
Mesalazine—Vertigo—Octreotide—thymus cancer	0.00051	0.00296	CcSEcCtD
Mesalazine—Syncope—Octreotide—thymus cancer	0.000509	0.00295	CcSEcCtD
Mesalazine—Palpitations—Octreotide—thymus cancer	0.000502	0.00291	CcSEcCtD
Mesalazine—CHUK—AKT phosphorylates targets in the cytosol—AKT1—thymus cancer	0.000502	0.011	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—DPYSL5—thymus cancer	0.000501	0.011	CbGpPWpGaD
Mesalazine—Loss of consciousness—Octreotide—thymus cancer	0.000499	0.0029	CcSEcCtD
Mesalazine—Cough—Octreotide—thymus cancer	0.000496	0.00288	CcSEcCtD
Mesalazine—PTGS1—thyroid gland—thymus cancer	0.000491	0.00879	CbGeAlD
Mesalazine—Hypertension—Octreotide—thymus cancer	0.00049	0.00284	CcSEcCtD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—CYLD—thymus cancer	0.000488	0.0107	CbGpPWpGaD
Mesalazine—Arthralgia—Octreotide—thymus cancer	0.000484	0.00281	CcSEcCtD
Mesalazine—Myalgia—Octreotide—thymus cancer	0.000484	0.00281	CcSEcCtD
Mesalazine—Chest pain—Octreotide—thymus cancer	0.000484	0.00281	CcSEcCtD
Mesalazine—Anxiety—Octreotide—thymus cancer	0.000482	0.0028	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00048	0.00279	CcSEcCtD
Mesalazine—Discomfort—Octreotide—thymus cancer	0.000478	0.00277	CcSEcCtD
Mesalazine—Dry mouth—Octreotide—thymus cancer	0.000473	0.00274	CcSEcCtD
Mesalazine—PTGS2—bone marrow—thymus cancer	0.00047	0.00842	CbGeAlD
Mesalazine—Oedema—Octreotide—thymus cancer	0.000463	0.00269	CcSEcCtD
Mesalazine—Anaphylactic shock—Octreotide—thymus cancer	0.000463	0.00269	CcSEcCtD
Mesalazine—Infection—Octreotide—thymus cancer	0.00046	0.00267	CcSEcCtD
Mesalazine—MPO—Folate Metabolism—IL2—thymus cancer	0.00046	0.0101	CbGpPWpGaD
Mesalazine—Shock—Octreotide—thymus cancer	0.000456	0.00265	CcSEcCtD
Mesalazine—Nervous system disorder—Octreotide—thymus cancer	0.000455	0.00264	CcSEcCtD
Mesalazine—Thrombocytopenia—Octreotide—thymus cancer	0.000454	0.00263	CcSEcCtD
Mesalazine—Tachycardia—Octreotide—thymus cancer	0.000452	0.00262	CcSEcCtD
Mesalazine—Skin disorder—Octreotide—thymus cancer	0.00045	0.00261	CcSEcCtD
Mesalazine—Hyperhidrosis—Octreotide—thymus cancer	0.000448	0.0026	CcSEcCtD
Mesalazine—PTGS1—lung—thymus cancer	0.000446	0.00798	CbGeAlD
Mesalazine—Anorexia—Octreotide—thymus cancer	0.000442	0.00256	CcSEcCtD
Mesalazine—MPO—C-MYB transcription factor network—CDKN2A—thymus cancer	0.000438	0.00957	CbGpPWpGaD
Mesalazine—PTGS2—lung—thymus cancer	0.000426	0.00763	CbGeAlD
Mesalazine—Musculoskeletal discomfort—Octreotide—thymus cancer	0.000422	0.00245	CcSEcCtD
Mesalazine—Insomnia—Octreotide—thymus cancer	0.000419	0.00243	CcSEcCtD
Mesalazine—Paraesthesia—Octreotide—thymus cancer	0.000416	0.00241	CcSEcCtD
Mesalazine—Dyspnoea—Octreotide—thymus cancer	0.000413	0.0024	CcSEcCtD
Mesalazine—MPO—C-MYB transcription factor network—CD4—thymus cancer	0.000412	0.00902	CbGpPWpGaD
Mesalazine—Somnolence—Octreotide—thymus cancer	0.000412	0.00239	CcSEcCtD
Mesalazine—Dyspepsia—Octreotide—thymus cancer	0.000408	0.00237	CcSEcCtD
Mesalazine—Decreased appetite—Octreotide—thymus cancer	0.000403	0.00234	CcSEcCtD
Mesalazine—CHUK—Downstream TCR signaling—CD4—thymus cancer	0.000401	0.00878	CbGpPWpGaD
Mesalazine—Gastrointestinal disorder—Octreotide—thymus cancer	0.0004	0.00232	CcSEcCtD
Mesalazine—Fatigue—Octreotide—thymus cancer	0.0004	0.00232	CcSEcCtD
Mesalazine—Constipation—Octreotide—thymus cancer	0.000396	0.0023	CcSEcCtD
Mesalazine—Pain—Octreotide—thymus cancer	0.000396	0.0023	CcSEcCtD
Mesalazine—Feeling abnormal—Octreotide—thymus cancer	0.000382	0.00222	CcSEcCtD
Mesalazine—Gastrointestinal pain—Octreotide—thymus cancer	0.000379	0.0022	CcSEcCtD
Mesalazine—CHUK—TCR Signaling Pathway—CD8A—thymus cancer	0.000372	0.00815	CbGpPWpGaD
Mesalazine—Urticaria—Octreotide—thymus cancer	0.000368	0.00214	CcSEcCtD
Mesalazine—Body temperature increased—Octreotide—thymus cancer	0.000366	0.00213	CcSEcCtD
Mesalazine—Abdominal pain—Octreotide—thymus cancer	0.000366	0.00213	CcSEcCtD
Mesalazine—IKBKB—Downstream TCR signaling—CD4—thymus cancer	0.000364	0.00796	CbGpPWpGaD
Mesalazine—CHUK—Validated transcriptional targets of TAp63 isoforms—CDKN2A—thymus cancer	0.000342	0.00748	CbGpPWpGaD
Mesalazine—Hypersensitivity—Octreotide—thymus cancer	0.000341	0.00198	CcSEcCtD
Mesalazine—IKBKB—TCR Signaling Pathway—CD8A—thymus cancer	0.000338	0.00739	CbGpPWpGaD
Mesalazine—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—thymus cancer	0.000336	0.00734	CbGpPWpGaD
Mesalazine—Asthenia—Octreotide—thymus cancer	0.000333	0.00193	CcSEcCtD
Mesalazine—Pruritus—Octreotide—thymus cancer	0.000328	0.0019	CcSEcCtD
Mesalazine—CHUK—Estrogen signaling pathway—AKT1—thymus cancer	0.000318	0.00696	CbGpPWpGaD
Mesalazine—Diarrhoea—Octreotide—thymus cancer	0.000317	0.00184	CcSEcCtD
Mesalazine—PPARG—Regulation of retinoblastoma protein—CDKN2A—thymus cancer	0.00031	0.00678	CbGpPWpGaD
Mesalazine—IKBKB—Validated transcriptional targets of TAp63 isoforms—CDKN2A—thymus cancer	0.00031	0.00678	CbGpPWpGaD
Mesalazine—Dizziness—Octreotide—thymus cancer	0.000307	0.00178	CcSEcCtD
Mesalazine—PTGS1—lymph node—thymus cancer	0.000305	0.00546	CbGeAlD
Mesalazine—CHUK—TCR signaling—CD4—thymus cancer	0.0003	0.00656	CbGpPWpGaD
Mesalazine—MPO—Folate Metabolism—TP53—thymus cancer	0.000295	0.00646	CbGpPWpGaD
Mesalazine—Vomiting—Octreotide—thymus cancer	0.000295	0.00171	CcSEcCtD
Mesalazine—Rash—Octreotide—thymus cancer	0.000292	0.0017	CcSEcCtD
Mesalazine—Dermatitis—Octreotide—thymus cancer	0.000292	0.00169	CcSEcCtD
Mesalazine—PTGS2—lymph node—thymus cancer	0.000291	0.00522	CbGeAlD
Mesalazine—Headache—Octreotide—thymus cancer	0.00029	0.00168	CcSEcCtD
Mesalazine—CHUK—Constitutive PI3K/AKT Signaling in Cancer—KIT—thymus cancer	0.00029	0.00635	CbGpPWpGaD
Mesalazine—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—thymus cancer	0.000289	0.00631	CbGpPWpGaD
Mesalazine—IKBKB—Estrogen signaling pathway—AKT1—thymus cancer	0.000288	0.00631	CbGpPWpGaD
Mesalazine—Nausea—Octreotide—thymus cancer	0.000275	0.0016	CcSEcCtD
Mesalazine—CHUK—TCR signaling in naïve CD4+ T cells—CD4—thymus cancer	0.000274	0.006	CbGpPWpGaD
Mesalazine—IKBKB—TCR signaling—CD4—thymus cancer	0.000272	0.00595	CbGpPWpGaD
Mesalazine—CHUK—PI-3K cascade—KIT—thymus cancer	0.000261	0.00572	CbGpPWpGaD
Mesalazine—CHUK—PI3K/AKT activation—KIT—thymus cancer	0.000255	0.00558	CbGpPWpGaD
Mesalazine—CHUK—GAB1 signalosome—KIT—thymus cancer	0.000253	0.00554	CbGpPWpGaD
Mesalazine—IKBKB—TCR signaling in naïve CD4+ T cells—CD4—thymus cancer	0.000249	0.00544	CbGpPWpGaD
Mesalazine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—KIT—thymus cancer	0.000247	0.00541	CbGpPWpGaD
Mesalazine—CHUK—Apoptosis—CDKN2A—thymus cancer	0.00024	0.00525	CbGpPWpGaD
Mesalazine—CHUK—FAS (CD95) signaling pathway—AKT1—thymus cancer	0.000227	0.00497	CbGpPWpGaD
Mesalazine—CHUK—Class I PI3K signaling events mediated by Akt—AKT1—thymus cancer	0.000227	0.00497	CbGpPWpGaD
Mesalazine—IKBKB—IL17 signaling pathway—AKT1—thymus cancer	0.000227	0.00497	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis—CDKN2A—thymus cancer	0.000218	0.00476	CbGpPWpGaD
Mesalazine—CHUK—TCR Signaling Pathway—CD4—thymus cancer	0.000214	0.00468	CbGpPWpGaD
Mesalazine—IKBKB—FAS (CD95) signaling pathway—AKT1—thymus cancer	0.000206	0.00451	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis Modulation and Signaling—CDKN2A—thymus cancer	0.000204	0.00447	CbGpPWpGaD
Mesalazine—CHUK—TWEAK Signaling Pathway—AKT1—thymus cancer	0.000196	0.0043	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—KIT—thymus cancer	0.000195	0.00427	CbGpPWpGaD
Mesalazine—IKBKB—TCR Signaling Pathway—CD4—thymus cancer	0.000194	0.00424	CbGpPWpGaD
Mesalazine—CHUK—Interleukin-11 Signaling Pathway—AKT1—thymus cancer	0.000189	0.00414	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling of activated FGFR—KIT—thymus cancer	0.000187	0.00409	CbGpPWpGaD
Mesalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—thymus cancer	0.000187	0.00408	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—KIT—thymus cancer	0.000184	0.00402	CbGpPWpGaD
Mesalazine—IKBKB—TWEAK Signaling Pathway—AKT1—thymus cancer	0.000178	0.0039	CbGpPWpGaD
Mesalazine—PPARG—Wnt Signaling Pathway Netpath—AKT1—thymus cancer	0.000176	0.00386	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—KIT—thymus cancer	0.000176	0.00384	CbGpPWpGaD
Mesalazine—PPARG—Generic Transcription Pathway—MAML2—thymus cancer	0.000176	0.00384	CbGpPWpGaD
Mesalazine—PTGS2—C-MYB transcription factor network—KIT—thymus cancer	0.000175	0.00383	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—KIT—thymus cancer	0.000175	0.00382	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—KIT—thymus cancer	0.000174	0.00381	CbGpPWpGaD
Mesalazine—CHUK—FoxO family signaling—AKT1—thymus cancer	0.000174	0.0038	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—KIT—thymus cancer	0.000173	0.00379	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CYLD—thymus cancer	0.000173	0.00377	CbGpPWpGaD
Mesalazine—IKBKB—Interleukin-11 Signaling Pathway—AKT1—thymus cancer	0.000172	0.00375	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—KIT—thymus cancer	0.000171	0.00373	CbGpPWpGaD
Mesalazine—CHUK—Signaling by Interleukins—IL2—thymus cancer	0.00017	0.00372	CbGpPWpGaD
Mesalazine—CHUK—TCR signaling in naïve CD8+ T cells—AKT1—thymus cancer	0.000163	0.00357	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—KIT—thymus cancer	0.000163	0.00356	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—KIT—thymus cancer	0.000163	0.00356	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—KIT—thymus cancer	0.000163	0.00356	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—KIT—thymus cancer	0.000161	0.00353	CbGpPWpGaD
Mesalazine—CHUK—IL-4 Signaling Pathway—AKT1—thymus cancer	0.000161	0.00351	CbGpPWpGaD
Mesalazine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—TP53—thymus cancer	0.00016	0.0035	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—KIT—thymus cancer	0.00016	0.0035	CbGpPWpGaD
Mesalazine—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—thymus cancer	0.000159	0.00349	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—KIT—thymus cancer	0.000159	0.00348	CbGpPWpGaD
Mesalazine—CHUK—IL-1 signaling pathway—AKT1—thymus cancer	0.000158	0.00346	CbGpPWpGaD
Mesalazine—CHUK—Cardiac Hypertrophic Response—AKT1—thymus cancer	0.000158	0.00346	CbGpPWpGaD
Mesalazine—CHUK—RANKL/RANK Signaling Pathway—AKT1—thymus cancer	0.000158	0.00346	CbGpPWpGaD
Mesalazine—IKBKB—FoxO family signaling—AKT1—thymus cancer	0.000157	0.00344	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CYLD—thymus cancer	0.000156	0.00342	CbGpPWpGaD
Mesalazine—CHUK—p75(NTR)-mediated signaling—TP53—thymus cancer	0.000156	0.00342	CbGpPWpGaD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KIT—thymus cancer	0.000155	0.00338	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by Interleukins—IL2—thymus cancer	0.000154	0.00338	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—KIT—thymus cancer	0.000151	0.0033	CbGpPWpGaD
Mesalazine—IKBKB—TCR signaling in naïve CD8+ T cells—AKT1—thymus cancer	0.000148	0.00323	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—KIT—thymus cancer	0.000148	0.00323	CbGpPWpGaD
Mesalazine—CHUK—Fc-epsilon receptor I signaling in mast cells—AKT1—thymus cancer	0.000146	0.00319	CbGpPWpGaD
Mesalazine—IKBKB—IL-4 Signaling Pathway—AKT1—thymus cancer	0.000146	0.00319	CbGpPWpGaD
Mesalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—thymus cancer	0.000145	0.00318	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—KIT—thymus cancer	0.000144	0.00316	CbGpPWpGaD
Mesalazine—IKBKB—IL-1 signaling pathway—AKT1—thymus cancer	0.000144	0.00314	CbGpPWpGaD
Mesalazine—IKBKB—RANKL/RANK Signaling Pathway—AKT1—thymus cancer	0.000144	0.00314	CbGpPWpGaD
Mesalazine—IKBKB—Cardiac Hypertrophic Response—AKT1—thymus cancer	0.000144	0.00314	CbGpPWpGaD
Mesalazine—PTGS2—C-MYB transcription factor network—CDKN2A—thymus cancer	0.000142	0.00311	CbGpPWpGaD
Mesalazine—IKBKB—p75(NTR)-mediated signaling—TP53—thymus cancer	0.000142	0.0031	CbGpPWpGaD
Mesalazine—PPARG—SREBP signalling—AKT1—thymus cancer	0.000141	0.00308	CbGpPWpGaD
Mesalazine—CHUK—TCR signaling in naïve CD4+ T cells—AKT1—thymus cancer	0.000137	0.00299	CbGpPWpGaD
Mesalazine—CHUK—AGE/RAGE pathway—AKT1—thymus cancer	0.000137	0.00299	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—KIT—thymus cancer	0.000137	0.00299	CbGpPWpGaD
Mesalazine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—AKT1—thymus cancer	0.000135	0.00296	CbGpPWpGaD
Mesalazine—CHUK—BCR signaling pathway—AKT1—thymus cancer	0.000135	0.00296	CbGpPWpGaD
Mesalazine—PTGS2—C-MYB transcription factor network—CD4—thymus cancer	0.000134	0.00293	CbGpPWpGaD
Mesalazine—CHUK—Apoptosis—TP53—thymus cancer	0.000134	0.00292	CbGpPWpGaD
Mesalazine—IKBKB—Fc-epsilon receptor I signaling in mast cells—AKT1—thymus cancer	0.000132	0.00289	CbGpPWpGaD
Mesalazine—CHUK—p75(NTR)-mediated signaling—AKT1—thymus cancer	0.000132	0.00289	CbGpPWpGaD
Mesalazine—IKBKB—TCR signaling in naïve CD4+ T cells—AKT1—thymus cancer	0.000124	0.00271	CbGpPWpGaD
Mesalazine—IKBKB—mTOR signaling pathway—AKT1—thymus cancer	0.000124	0.00271	CbGpPWpGaD
Mesalazine—IKBKB—AGE/RAGE pathway—AKT1—thymus cancer	0.000124	0.00271	CbGpPWpGaD
Mesalazine—CHUK—Leptin signaling pathway—AKT1—thymus cancer	0.000123	0.0027	CbGpPWpGaD
Mesalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—AKT1—thymus cancer	0.000123	0.00268	CbGpPWpGaD
Mesalazine—IKBKB—BCR signaling pathway—AKT1—thymus cancer	0.000123	0.00268	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis—TP53—thymus cancer	0.000121	0.00265	CbGpPWpGaD
Mesalazine—IKBKB—p75(NTR)-mediated signaling—AKT1—thymus cancer	0.00012	0.00262	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis Modulation and Signaling—TP53—thymus cancer	0.000114	0.00249	CbGpPWpGaD
Mesalazine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—AKT1—thymus cancer	0.000113	0.00247	CbGpPWpGaD
Mesalazine—CHUK—Apoptosis—AKT1—thymus cancer	0.000113	0.00247	CbGpPWpGaD
Mesalazine—IKBKB—Leptin signaling pathway—AKT1—thymus cancer	0.000112	0.00245	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—KIT—thymus cancer	0.000111	0.00243	CbGpPWpGaD
Mesalazine—CHUK—Constitutive PI3K/AKT Signaling in Cancer—AKT1—thymus cancer	0.000111	0.00242	CbGpPWpGaD
Mesalazine—CHUK—TCR Signaling Pathway—AKT1—thymus cancer	0.000107	0.00234	CbGpPWpGaD
Mesalazine—CHUK—TNF alpha Signaling Pathway—AKT1—thymus cancer	0.000105	0.00229	CbGpPWpGaD
Mesalazine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—AKT1—thymus cancer	0.000102	0.00224	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis—AKT1—thymus cancer	0.000102	0.00224	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—KIT—thymus cancer	0.000101	0.0022	CbGpPWpGaD
Mesalazine—CHUK—B Cell Receptor Signaling Pathway—AKT1—thymus cancer	0.000101	0.0022	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CYLD—thymus cancer	0.0001	0.0022	CbGpPWpGaD
Mesalazine—CHUK—PI-3K cascade—AKT1—thymus cancer	9.97e-05	0.00218	CbGpPWpGaD
Mesalazine—CHUK—PI3K/AKT activation—AKT1—thymus cancer	9.73e-05	0.00213	CbGpPWpGaD
Mesalazine—IKBKB—TCR Signaling Pathway—AKT1—thymus cancer	9.68e-05	0.00212	CbGpPWpGaD
Mesalazine—CHUK—GAB1 signalosome—AKT1—thymus cancer	9.66e-05	0.00211	CbGpPWpGaD
Mesalazine—CHUK—Toll-like Receptor Signaling Pathway—AKT1—thymus cancer	9.66e-05	0.00211	CbGpPWpGaD
Mesalazine—IKBKB—TNF alpha Signaling Pathway—AKT1—thymus cancer	9.51e-05	0.00208	CbGpPWpGaD
Mesalazine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—thymus cancer	9.44e-05	0.00206	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—IL2—thymus cancer	9.39e-05	0.00205	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Receptor Signaling Pathway—AKT1—thymus cancer	9.12e-05	0.00199	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CYLD—thymus cancer	9.11e-05	0.00199	CbGpPWpGaD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—AKT1—thymus cancer	8.76e-05	0.00192	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—MAML2—thymus cancer	8.45e-05	0.00185	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—TP53—thymus cancer	8.36e-05	0.00183	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CD8A—thymus cancer	8.09e-05	0.00177	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL2—thymus cancer	7.94e-05	0.00174	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—AKT1—thymus cancer	7.54e-05	0.00165	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—AKT1—thymus cancer	7.45e-05	0.00163	CbGpPWpGaD
Mesalazine—CHUK—Disease—MAML2—thymus cancer	7.37e-05	0.00161	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CD8A—thymus cancer	7.34e-05	0.00161	CbGpPWpGaD
Mesalazine—CHUK—BDNF signaling pathway—AKT1—thymus cancer	7.33e-05	0.0016	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL2—thymus cancer	7.2e-05	0.00158	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling of activated FGFR—AKT1—thymus cancer	7.13e-05	0.00156	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—TP53—thymus cancer	7.08e-05	0.00155	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—AKT1—thymus cancer	7.06e-05	0.00154	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—AKT1—thymus cancer	7.02e-05	0.00154	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TP53—thymus cancer	6.96e-05	0.00152	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	6.92e-05	0.00151	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—thymus cancer	6.84e-05	0.0015	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—AKT1—thymus cancer	6.7e-05	0.00147	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—AKT1—thymus cancer	6.67e-05	0.00146	CbGpPWpGaD
Mesalazine—IKBKB—BDNF signaling pathway—AKT1—thymus cancer	6.65e-05	0.00145	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—AKT1—thymus cancer	6.64e-05	0.00145	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—AKT1—thymus cancer	6.6e-05	0.00145	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thymus cancer	6.51e-05	0.00142	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—KIT—thymus cancer	6.33e-05	0.00138	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—AKT1—thymus cancer	6.21e-05	0.00136	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—AKT1—thymus cancer	6.21e-05	0.00136	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	6.21e-05	0.00136	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—AKT1—thymus cancer	6.16e-05	0.00135	CbGpPWpGaD
Mesalazine—IKBKB—Insulin Signaling—AKT1—thymus cancer	6.11e-05	0.00134	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—AKT1—thymus cancer	6.1e-05	0.00134	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—AKT1—thymus cancer	6.08e-05	0.00133	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—KIT—thymus cancer	6.08e-05	0.00133	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TP53—thymus cancer	6.03e-05	0.00132	CbGpPWpGaD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thymus cancer	5.9e-05	0.00129	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—AKT1—thymus cancer	5.87e-05	0.00129	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	5.85e-05	0.00128	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—AKT1—thymus cancer	5.75e-05	0.00126	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—KIT—thymus cancer	5.74e-05	0.00126	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	5.63e-05	0.00123	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—KIT—thymus cancer	5.51e-05	0.00121	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	5.5e-05	0.0012	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—AKT1—thymus cancer	5.21e-05	0.00114	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MAML2—thymus cancer	5.16e-05	0.00113	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD8A—thymus cancer	4.91e-05	0.00107	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CD4—thymus cancer	4.84e-05	0.00106	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MAML2—thymus cancer	4.68e-05	0.00102	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CD4—thymus cancer	4.65e-05	0.00102	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD8A—thymus cancer	4.45e-05	0.000974	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CD4—thymus cancer	4.39e-05	0.00096	CbGpPWpGaD
Mesalazine—PTGS2—Disease—MAML2—thymus cancer	4.37e-05	0.000955	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—AKT1—thymus cancer	4.23e-05	0.000926	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CD4—thymus cancer	4.21e-05	0.000922	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	4.1e-05	0.000897	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—AKT1—thymus cancer	3.84e-05	0.00084	CbGpPWpGaD
Mesalazine—CHUK—Immune System—KIT—thymus cancer	3.68e-05	0.000806	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	3.46e-05	0.000758	CbGpPWpGaD
Mesalazine—CHUK—Disease—KIT—thymus cancer	3.4e-05	0.000744	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—KIT—thymus cancer	3.34e-05	0.000731	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—AKT1—thymus cancer	2.91e-05	0.000637	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD4—thymus cancer	2.82e-05	0.000617	CbGpPWpGaD
Mesalazine—CHUK—Disease—CD4—thymus cancer	2.6e-05	0.000569	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL2—thymus cancer	2.59e-05	0.000567	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD4—thymus cancer	2.56e-05	0.000559	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—AKT1—thymus cancer	2.41e-05	0.000528	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—KIT—thymus cancer	2.38e-05	0.000521	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL2—thymus cancer	2.35e-05	0.000514	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—AKT1—thymus cancer	2.32e-05	0.000507	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—AKT1—thymus cancer	2.19e-05	0.000479	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—KIT—thymus cancer	2.16e-05	0.000473	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—AKT1—thymus cancer	2.1e-05	0.00046	CbGpPWpGaD
Mesalazine—PTGS2—Disease—KIT—thymus cancer	2.02e-05	0.000441	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—AKT1—thymus cancer	1.87e-05	0.000409	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL2—thymus cancer	1.68e-05	0.000367	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CD4—thymus cancer	1.54e-05	0.000337	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL2—thymus cancer	1.52e-05	0.000333	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—AKT1—thymus cancer	1.49e-05	0.000326	CbGpPWpGaD
Mesalazine—CHUK—Immune System—AKT1—thymus cancer	1.41e-05	0.000308	CbGpPWpGaD
Mesalazine—CHUK—Disease—AKT1—thymus cancer	1.3e-05	0.000284	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—AKT1—thymus cancer	1.27e-05	0.000279	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—AKT1—thymus cancer	1.16e-05	0.000253	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TP53—thymus cancer	1.08e-05	0.000236	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TP53—thymus cancer	9.76e-06	0.000214	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—AKT1—thymus cancer	9.09e-06	0.000199	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—AKT1—thymus cancer	8.24e-06	0.00018	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—AKT1—thymus cancer	8.11e-06	0.000178	CbGpPWpGaD
Mesalazine—PTGS2—Disease—AKT1—thymus cancer	7.69e-06	0.000168	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—AKT1—thymus cancer	6.44e-06	0.000141	CbGpPWpGaD
